Literature DB >> 10484325

Status of Ca2+/calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion.

T Netticadan1, R Temsah, M Osada, N S Dhalla.   

Abstract

Although the sarcoplasmic reticulum (SR) is known to regulate the intracellular concentration of Ca2+ and the SR function has been shown to become abnormal during ischemia-reperfusion in the heart, the mechanisms for this defect are not fully understood. Because phosphorylation of SR proteins plays a crucial role in the regulation of SR function, we investigated the status of endogenous Ca2+/calmodulin-dependent protein kinase (CaMK) and exogenous cAMP-dependent protein kinase (PKA) phosphorylation of the SR proteins in control, ischemic (I), and ischemia-reperfused (I/R) hearts treated or not treated with superoxide dismutase (SOD) plus catalase (CAT). SR and cytosolic fractions were isolated from control, I, and I/R hearts treated or not treated with SOD plus CAT, and the SR protein phosphorylation by CaMK and PKA, the CaMK- and PKA-stimulated Ca2+ uptake, and the CaMK, PKA, and phosphatase activities were studied. The SR CaMK and CaMK-stimulated Ca2+ uptake activities, as well as CaMK phosphorylation of Ca2+ pump ATPase (SERCA2a) and phospholamban (PLB), were significantly decreased in both I and I/R hearts. The PKA phosphorylation of PLB and PKA-stimulated Ca2+ uptake were reduced significantly in the I/R hearts only. Cytosolic CaMK and PKA activities were unaltered, whereas SR phosphatase activity in the I and I/R hearts was depressed. SOD plus CAT treatment prevented the observed alterations in SR CaMK and phosphatase activities, CaMK and PKA phosphorylations, and CaMK- and PKA-stimulated Ca2+ uptake. These results indicate that depressed CaMK phosphorylation and CaMK-stimulated Ca2+ uptake in I/R hearts may be due to a depression in the SR CaMK activity. Furthermore, prevention of the I/R-induced alterations in SR protein phosphorylation by SOD plus CAT treatment is consistent with the role of oxidative stress during ischemia-reperfusion injury in the heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484325     DOI: 10.1152/ajpcell.1999.277.3.C384

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr(17) residue.

Authors:  A Mattiazzi; C Mundiña-Weilenmann; L Vittone; M Said
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 2.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 3.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 4.  Structure-function relationships and modifications of cardiac sarcoplasmic reticulum Ca2+-transport.

Authors:  M Nusier; A K Shah; N S Dhalla
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

5.  Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase.

Authors:  Pratima Tripathi; M Chandra; Mithilesh K Misra
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

Review 6.  Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy.

Authors:  Elliott J F Cantor; Enrico V Mancini; Rishi Seth; Xing-Hai Yao; Thomas Netticadan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

7.  Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17.

Authors:  Daniele Catalucci; Michael V G Latronico; Marcello Ceci; Francesca Rusconi; Howard S Young; Paolo Gallo; Marco Santonastasi; Alfonso Bellacosa; Joan Heller Brown; Gianluigi Condorelli
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

8.  Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.

Authors:  Cecilia Mundiña-Weilenmann; Matilde Said; Leticia Vittone; Paola Ferrero; Alicia Mattiazzi
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

9.  Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.

Authors:  Zainisha Vasanji; Naranjan S Dhalla; Thomas Netticadan
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

10.  Endoplasmic Reticulum Is Involved in Myocardial Injury in a Miniature Swine Model of Coronary Artery Stenosis Exposed to Acceleration-Associated Stress.

Authors:  Haitao Zhang; Meng Chai; Chaozhong Liu; Jinjin Sun; Congchun Huang; Xinya Yu; Yi Tian; Huilan Luo
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.